Senores Pharmaceuticals shares fall 3% despite 22% rise in Q2 profit; revenue jumps 25%

Senores Pharmaceuticals reported strong Q2 results with revenue up 24.7% and net profit rising 22.3%, despite its shares facing downward pressure.